ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($53.35 B vs $30.65 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARGX | RVMD |
|---|---|---|
| Market cap | $53.35 B | $30.65 B |
| US-listed rank | #306 | #455 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | - | -$1.13B |
| SEC filings | 272 | 782 |
ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($53.35 B vs $30.65 B).
Full pages: ARGENX SE and Revolution Medicines, Inc., or browse the full rankings.